Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026)
Relmada Therapeutics (RLMD) posted Selling, General & Administrative of $6.62 million for Q2 2026, down 10.6% from $7.4 million a year earlier and down 41.8% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Relmada Therapeutics was $36.54 million, up 8.7% year-over-year; for FY2025, it came in at $32.22 million, down 14.6% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
- In prior years, Relmada Therapeutics' Selling, General & Administrative was $37.72 million in FY2024 (-22.9%), $48.89 million in FY2023 (+2.0%), $47.93 million in FY2022 (+36.6%) and $35.08 million in FY2021 (+41.1%).
- Quarterly Selling, General & Administrative has run from a low of $6.27 million in Q1 2025 to a high of $14.6 million in Q2 2022 over five years.
- On a year-over-year basis, Selling, General & Administrative increased in two of the last eight quarters, with an average decline of 0.5%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q1 2026, with growth of 81.5%; the weakest was Q3 2025, with a decline of 47.0%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $11.37 million (Q1 2026), $12.26 million (Q4 2025) and $6.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Relmada Therapeutics | 390.41 Mn | 390.41 Mn | - | 6.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.62 Mn |
| Mar 31, 2026 | 11.37 Mn |
| Dec 31, 2025 | 12.26 Mn |
| Sep 30, 2025 | 6.29 Mn |
| Jun 30, 2025 | 7.40 Mn |
| Mar 31, 2025 | 6.27 Mn |
| Dec 31, 2024 | 8.08 Mn |
| Sep 30, 2024 | 11.86 Mn |
| Jun 30, 2024 | 8.10 Mn |
| Mar 31, 2024 | 9.68 Mn |
| Dec 31, 2023 | 12.08 Mn |
| Sep 30, 2023 | 12.24 Mn |
| Jun 30, 2023 | 12.29 Mn |
| Mar 31, 2023 | 12.29 Mn |
| Dec 31, 2022 | 11.83 Mn |
| Sep 30, 2022 | 8.21 Mn |
| Jun 30, 2022 | 14.60 Mn |
| Mar 31, 2022 | 13.28 Mn |
| Dec 31, 2021 | 8.91 Mn |
| Sep 30, 2021 | 8.66 Mn |
API Access
Relmada Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();